Global Oncology Companion Diagnostic Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by Product &
Service; Product - Instrument, Consumables and Software, Service.Segmented by Technology;
Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH) and Other Technologies.Segmented by Disease Type;
Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Leukemia, Melanoma, Prostate Cancer and Others.Segmented by End-Use;
Hospital, Pathology/Diagnostic Laboratory and Academic Medical Center.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Oncology Companion Diagnostic Market (USD Million), 2020 - 2030
# | Global |
---|---|
2020 | 58.9 |
2021 | 64.6 |
2022 | 72.5 |
2023 | 86.6 |
2024 | 92.2 |
2025 | 92.5 |
2026 | 110.4 |
2027 | 129.4 |
2028 | 137.4 |
2029 | 157.9 |
2030 | 177.2 |
In the year 2023, the Global Oncology Companion Diagnostic Market was valued at USD 3,367.42 million. The size of this market is expected to increase to USD 7,873.27 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 12.9%.
Global Oncology Companion Diagnostic Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Oncology Companion Diagnostic Market |
Study Period | 2020 - 2030 |
Base Year (for Oncology Companion Diagnostic Market Size Estimates) | 2023 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Oncology Companion Diagnostic Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Oncology Companion Diagnostic Market Analysis
In this report, the Global Oncology Companion Diagnostic Market has been segmented by Product & Service, Technology, Disease Type, End-Use and Geography.
Global Oncology Companion Diagnostic Market, Segmentation by Product & Service
The Global Oncology Companion Diagnostic Market has been segmented by Product & Service into Product and Service. The complete Global Oncology Companion Diagnostic Market segmentation by Product & Service can be seen below:
- Global Oncology Companion Diagnostic Market, By Product & Service
- Product
- Instrument
- Consumables
- Software
- Service
- Product
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Product & Services mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Product & Service is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Oncology Companion Diagnostic Market, by Product & Service (USD Million), 2020 - 2030
# | Product | Service |
---|---|---|
2020 | 59.1 | 64.8 |
2021 | 67.8 | 74.7 |
2022 | 80.4 | 88.1 |
2023 | 86.8 | 99.0 |
2024 | 95.1 | 108.5 |
2025 | 106.5 | 126.6 |
2026 | 109.5 | 150.9 |
2027 | 110.2 | 159.7 |
2028 | 127.4 | 175.0 |
2029 | 142.9 | 204.0 |
2030 | 161.9 | 232.4 |
Global Oncology Companion Diagnostic Market, Segmentation by Technology
The Global Oncology Companion Diagnostic Market has been segmented by Technology into Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH) and Other Technologies. The complete Global Oncology Companion Diagnostic Market segmentation by Technology can be seen below:
- Global Oncology Companion Diagnostic Market, By Technology
- Polymerase Chain Reaction (PCR)
- Next-Generation Sequencing (NGS)
- Immunohistochemistry (IHC)
- In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
- Other Technologies
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Technologys mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Technology is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Oncology Companion Diagnostic Market, by Technology (USD Million), 2020 - 2030
# | Polymerase Chain Reaction (PCR) | Next-Generation Sequencing (NGS) | Immunohistochemistry (IHC) | In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH) | Other Technologies |
---|---|---|---|---|---|
2020 | 91.1 | 69.4 | 110.6 | 71.4 | 71.7 |
2021 | 108.1 | 80.4 | 128.3 | 76.2 | 73.2 |
2022 | 117.4 | 88.8 | 146.7 | 88.3 | 81.1 |
2023 | 131.5 | 102.3 | 158.2 | 100.2 | 89.4 |
2024 | 138.3 | 119.4 | 180.9 | 103.3 | 98.6 |
2025 | 146.6 | 124.8 | 198.6 | 119.9 | 108.9 |
2026 | 171.2 | 141.8 | 201.1 | 130.2 | 126.6 |
2027 | 197.9 | 158.0 | 226.0 | 135.4 | 142.9 |
2028 | 205.4 | 182.9 | 238.3 | 136.0 | 152.0 |
2029 | 241.4 | 196.4 | 273.3 | 150.3 | 171.4 |
2030 | 242.8 | 226.9 | 286.7 | 178.3 | 177.8 |
Global Oncology Companion Diagnostic Market, Segmentation by Disease Type
The Global Oncology Companion Diagnostic Market has been segmented by Disease Type into Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Leukemia, Melanoma, Prostate Cancer and Others. The complete Global Oncology Companion Diagnostic Market segmentation by Disease Type can be seen below:
- Global Oncology Companion Diagnostic Market, By Disease Type
- Breast Cancer
- Non-Small Cell Lung Cancer
- Colorectal Cancer
- Leukemia
- Melanoma
- Prostate Cancer
- Others
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Disease Types mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Disease Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Oncology Companion Diagnostic Market, by Disease Type (USD Million), 2020 - 2030
# | Breast Cancer | Non-Small Cell Lung Cancer | Colorectal Cancer | Leukemia | Melanoma | Prostate Cancer | Others |
---|---|---|---|---|---|---|---|
2020 | 84.6 | 98.4 | 96.4 | 75.0 | 70.9 | 99.9 | 72.6 |
2021 | 96.0 | 116.3 | 104.7 | 83.7 | 79.0 | 110.6 | 84.2 |
2022 | 107.8 | 124.1 | 112.2 | 94.0 | 92.7 | 118.8 | 97.2 |
2023 | 126.7 | 133.7 | 115.5 | 99.3 | 95.8 | 129.8 | 105.1 |
2024 | 146.7 | 139.4 | 128.9 | 111.9 | 113.6 | 141.3 | 112.2 |
2025 | 170.5 | 153.1 | 131.0 | 129.3 | 132.8 | 147.8 | 130.1 |
2026 | 189.6 | 159.2 | 132.1 | 145.6 | 149.7 | 166.1 | 135.8 |
2027 | 206.0 | 179.5 | 147.9 | 160.7 | 153.1 | 178.2 | 145.9 |
2028 | 215.8 | 197.9 | 157.4 | 179.8 | 159.7 | 190.7 | 155.5 |
2029 | 254.9 | 220.0 | 186.3 | 209.4 | 159.9 | 192.2 | 155.5 |
2030 | 266.1 | 237.5 | 217.9 | 222.8 | 180.6 | 211.3 | 183.2 |
Global Oncology Companion Diagnostic Market, Segmentation by End-Use
The Global Oncology Companion Diagnostic Market has been segmented by End-Use into Hospital, Pathology/Diagnostic Laboratory and Academic Medical Center. The complete Global Oncology Companion Diagnostic Market segmentation by End-Use can be seen below:
- Global Oncology Companion Diagnostic Market, By End-Use
- Hospital
- Pathology/Diagnostic Laboratory
- Academic Medical Center
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the End-Uses mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by End-Use is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Oncology Companion Diagnostic Market, by End-Use (USD Million), 2020 - 2030
# | Hospital | Pathology/Diagnostic Laboratory | Academic Medical Center |
---|---|---|---|
2020 | 103.7 | 105.1 | 68.4 |
2021 | 123.9 | 114.0 | 76.1 |
2022 | 139.3 | 121.4 | 77.9 |
2023 | 154.1 | 127.0 | 78.1 |
2024 | 154.3 | 145.3 | 78.9 |
2025 | 176.3 | 156.8 | 89.2 |
2026 | 179.2 | 167.6 | 106.8 |
2027 | 207.8 | 195.7 | 122.3 |
2028 | 219.2 | 224.9 | 136.8 |
2029 | 241.2 | 230.2 | 142.6 |
2030 | 256.2 | 255.6 | 164.6 |
Global Oncology Companion Diagnostic Market, Segmentation by Geography
In this report, the Global Oncology Companion Diagnostic Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Oncology Companion Diagnostic Market Share (%), by Geographical Region, 2023
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Oncology Companion Diagnostic Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Oncology Companion Diagnostic in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Oncology Companion Diagnostic Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The growth of the Global Oncology Companion Diagnostic Market is driven by; Accelerating demand for targeted cancer treatment & tailored drugs, Collaborations between diagnostic and pharma entities, Rise in approval rate for companion diagnostics and Rise in cancer incidence across the globe.
- While the growth of Global Oncology Companion Diagnostic Market is currently hindered by; Broken clinical diagnostic testing landscape and Constraints associated with the clinical implementation of companion diagnostic tests.
- Global Oncology Companion Diagnostic Market has good growth potential in the future due to the new market opportunities that are being created. The opportunities in this market include; Increase in adoption of companion diagnostics for precision medicine.
- Accelerating demand for targeted cancer treatment & tailored drugs.
- Collaborations between diagnostic and pharma entities.
- Rise in approval rate for companion diagnostics.
- Rise in cancer incidence across the globe.
- Broken clinical diagnostic testing landscape.
- Constraints associated with the clinical implementation of companion diagnostic tests.
- Increase in adoption of companion diagnostics for precision medicine.
Market Opportunity Map
This report provides market opportunity map for Oncology Companion Diagnostic Market. The opportunity map (by market segments; Product & Service, Technology, Disease Type and End-Use) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Oncology Companion Diagnostic Market, Opportunity Map, By Region (2020 - 2030)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Oncology Companion Diagnostic Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Oncology Companion Diagnostic Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Oncology Companion Diagnostic Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value. Oncology companion diagnostics are important because pharmacotherapy responses vary greatly. Examples of companion diagnostics include camptosar, herceptin, purinethol, and others. Companion diagnostics companies include Roche Diagnostics, Qiagen, and Abbott Diagnostics. The roche digital pathology solution combines innovative hardware, software, and ventana companion algorithm image analysis software, and it works in unison with the rest of the roche diagnostic portfolio to provide an end-to-end experience. The FDA also approved Ventana, a companion diagnostic test for identifying patients who are candidates for adjuvant treatment with atezolizumab. The ventana pd-l1 (sp263) assay was used in the impower010 study, which was funded by Genentech, a Roche group company. The mayonnaise industry is divided into two parts: unflavored mayonnaise and flavored mayonnaise. Ossotide has been shown to promote osteoblast differentiation as an effective bone formation compound preparation. The smart watch market report is a compilation of first-hand information, qualitative and quantitative analysis by industry analysts, and inputs from industry experts and value chain participants. India's largest snack companies are Nestle is India's largest food company, and some of the most popular snack brands in India include pratap snacks, balaji wafers, dfm foods, bikanervala, haldirams, and pepsico india. Automobile ancillary manufacturers are inextricably linked to the automobile industry. Increased consumer awareness and interest in a healthy lifestyle has resulted in an increase in demand for healthy ready-to-drink products. The plywood industry has entered a period of fierce competition. Players in the sanitary ware industry can benefit from new marketing options by targeting brand-conscious consumers, particularly in emerging markets. Understanding the facial growth trend is critical in orthodontic treatment. It features products that are heavily promoted on the eponymous television channel and in commercials. Vietnam is the world's leading producer of cashews and a significant exporter to other international markets.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Oncology Companion Diagnostic Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Oncology Companion Diagnostic Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Oncology Companion Diagnostic Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Oncology Companion Diagnostic Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Oncology Companion Diagnostic Market include, QIAGEN, Illumina, Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., ARUP Laboratories, Abbott, Myriad Genetics, Inc., bioMrieux SA and Invivoscribe.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product & Service
- Market Snapshot, By Technology
- Market Snapshot, By Disease Type
- Market Snapshot, By End-Use
- Market Snapshot, By Region
- Market Opportunity Map
- Global Oncology Companion Diagnostic Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Accelerating demand for targeted cancer treatment & tailored drugs
- Collaborations between diagnostic and pharma entities
- Rise in approval rate for companion diagnostics
- Rise in cancer incidence across the globe
- Restraints
- Broken clinical diagnostic testing landscape
- Constraints associated with the clinical implementation of companion diagnostic tests
- Opportunities
- Increase in adoption of companion diagnostics for precision medicine
- Drivers
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Oncology Companion Diagnostic Market, By Product & Service, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Product
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Instrument
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Instrument
- Service
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Product
- Global Oncology Companion Diagnostic Market, By Technology, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Immunohistochemistry (IHC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Other Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Polymerase Chain Reaction (PCR)
- Global Oncology Companion Diagnostic Market, By Disease Type, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Non-Small Cell Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Leukemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Melanoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Breast Cancer
- Global Oncology Companion Diagnostic Market, By End-Use, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Pathology/Diagnostic Laboratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Academic Medical Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Hospital
- Global Oncology Companion Diagnostic Market, By Geography, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Japan
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Brazil
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2020 - 2030 (USD Million)
- GCC
- North America
- Global Oncology Companion Diagnostic Market, By Product & Service, 2022 - 2032 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- QIAGEN
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Illumina, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- F. Hoffmann-La Roche Ltd.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Thermo Fisher Scientific, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Agilent Technologies, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- ARUP Laboratories
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Abbott
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Myriad Genetics, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- bioMérieux SA
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Invivoscribe, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- QIAGEN
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Oncology Devices Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Online Patient Observation Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Open MRI Systems Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Operating Room Integration Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%